Clinical Trials Browser

INDUSTRY × Autoimmune Diseases × Clear all

NCT07039916 2026-03-06

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Phase 3 Recruiting

231 enrolled

Autoimmune Diseases, Myasthenia Gravis

NCT06626919 2026-02-25

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Phase 1 Recruiting

30 enrolled

Autoimmune Diseases, Muscular Diseases, Myasthenia Gravis, Muscle Weakness, Autoimmune Diseases of the Nervous System, Neuromuscular Manifestations

NCT06193889 2026-01-30

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Phase 2/3 Recruiting

66 enrolled

Autoimmune Diseases, Myasthenia Gravis

NCT05451212 2025-11-10

Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis

Phase 1 Completed

7 enrolled

Autoimmune Diseases, Immune System Diseases, Musculoskeletal Diseases, Myasthenia Gravis, Neuromuscular Diseases, Muscle Weakness

NCT05737160 2025-05-23

Study of Telitacicept in Generalized Myasthenia Gravis

Phase 3 Completed

114 enrolled

Autoimmune Diseases, Myasthenia Gravis, Muscle Weakness

NCT03283826 2024-02-23

EMBOLD

Phase 1/2 Terminated

134 enrolled

Autoimmune Diseases, Demyelinating Diseases, Inflammation, Multiple Sclerosis, Epstein-Barr Virus Infections, Multiple Sclerosis, Chronic Progressive

NCT06035614 2023-09-13

Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children

Phase NA Completed

50 enrolled

LymphoidOther hematologic neoplasm

Autoimmune Diseases, Skin Diseases, Vitiligo, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03884400 2022-11-14

Distribution of Biospecimens From Biorepositories/Biobanks for Research Use

Withdrawn

Autoimmune Diseases, Digestive System Diseases, Neoplasms, Nephritis

NCT03848962 2022-11-09

Collection and Distribution of Biospecimens for Novel Research Uses

Recruiting

10,000 enrolled

Autoimmune Diseases, Communicable Diseases, Hematologic Diseases, Neoplasms, Skin Diseases

NCT05080907 2022-11-09

Collection and Distribution of Biospecimens for Novel Research

Unknown

100,000 enrolled

Autoimmune Diseases, Communicable Diseases, Hematologic Diseases, Neoplasms, Skin Diseases

NCT03348046 2020-03-04

PASSRRA

Completed

22 enrolled

Arthritis, Rheumatoid, Autoimmune Diseases

NCT01953822 2016-12-26

Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United Kingdom

Completed

1,053 enrolled

Autoimmune Diseases, Papillomavirus Infections

NCT01498627 2015-04-06

PGRx

Completed

2,945 enrolled

Autoimmune Diseases, Papillomavirus Infections

NCT01153906 2014-12-02

Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination

Completed

1,516 enrolled

Autoimmune Diseases, Papillomavirus Infections

NCT00731536 2013-10-16

Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of Netherlands

Completed

15 enrolled

Lymphoid

Autoimmune Diseases, Lymphoma, Non-Hodgkin

NCT01210716 2013-09-23

Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device

Phase 3 Completed

37 enrolled 7 charts

Genitourinary

Autoimmune Diseases, Hematologic Diseases, Kidney Diseases, Nervous System Diseases, Paraproteinemias